Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel in Recurrent Uterine Papillary Serous Carcinoma
NCT00022620Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jun 2001
- Primary completion
- Oct 2002
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in uterine papillary serous carcinoma (UPSC), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Objective Response. Started Jun 2001; status: completed.
02
Drugs
paclitaxel
03
Conditions
uterine papillary serous carcinoma (UPSC)
Beyond the preview
Go deeper on NCT00022620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022620.